| ARCT latest price $143.3600 (13.09%) ($129.4000 - $145.9500) on Wed. Oct. 2, 2013. |
|
|
| Trend Analysis and Forecast |
| |
Average Daily Percentage Swing | 5.23% (three month average) |
RSI | 73 |
Latest Price | $143.3600(13.09%) |
Stocks Behave Similarly | Similar Stock List |
Daily Trend | ARCT advances 5.2% a day on average for past five trading days. |
Weekly Trend | ARCT advances 8.5% a week on average for past two weeks. |
Market Behavior | Normal for large cap. Normal for small cap. |
Correlated ETFs | Broad market will support ARCT advance at 0% a week (0% probability) IWM(4%) XOP(4%) VWO(2%) BNDX(1%) EEM(1%) |
Factors Impacting ARCT price | ARCT will decline at least -2.615% in a week (0% probabilities). LQD(-4%) XLU(-3%) IGOV(-2%) GLD(-2%) XLP(-1%) |
Explanation | The rally is not sustainable and not supported by the broad market. |
| |
| |
Relative Volatility | (options are extremely cheap) |
| |
Market Trend Strength | -2.615% (StdDev 5.23%) |
Hourly BBV | 0 () |
Intraday Trend | 10.7% |
| |
|
|
July 7, 2020 ARCT develops mRNA based covid vaccine. Now it's still in preclinical stage, and plan to start phase I clinic trail this summer.